−0.00GBP
−1.74 MGBP
200.00 KGBP
72.56 M
About ROQUEFORT THERAPEUTICS PLC ORD GBP0.01
Sector
CEO
Ajan Trevor Reginald
Headquarters
London
Website
Founded
2020
ISIN
GB00BMDQ2T15
FIGI
BBG00ZR5QNL9
Roquefort Therapeutics Plc operates as an investment company. It was formed to acquire medical biotechnology businesses that are focused on early stage opportunities to include drug and vaccine development, diagnostics, immuno-therapy, and cell and gene therapies. The company was founded on August 17, 2020 and is headquartered in London, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ROQ is 6.25 GBX — it has increased by 19.05% in the past 24 hours. Watch ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 stocks are traded under the ticker ROQ.
ROQ stock has risen by 56.25% compared to the previous week, the month change is a 74.58% rise, over the last year ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 has showed a −7.20% decrease.
ROQ stock is 22.73% volatile and has beta coefficient of −0.26. Track ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 stock price on the chart and check out the list of the most volatile stocks — is ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 there?
Today ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 has the market capitalization of 6.78 M, it has increased by 31.08% over the last week.
Yes, you can track ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
ROQ net income for the last half-year is −579.50 K GBP, while the previous report showed −962.18 K GBP of net income which accounts for 39.77% change. Track more ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 financial stats to get the full picture.
No, ROQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 EBITDA is −1.67 M GBP, and current EBITDA margin is −964.88%. See more stats in ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 financial statements.
Like other stocks, ROQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 stock shows the buy signal. See more of ROQUEFORT THERAPEUTICS PLC ORD GBP0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.